{"id":21981,"date":"2025-11-18T20:34:46","date_gmt":"2025-11-18T19:34:46","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=21981"},"modified":"2026-05-21T22:51:28","modified_gmt":"2026-05-21T20:51:28","slug":"cjc-1295-ipamoreliinin-10mg-kanssa","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/fi\/shop\/cjc-1295-with-ipamorelin-10mg\/","title":{"rendered":"CJC-1295 ja ipamoreliini 10 mg:n kanssa"},"content":{"rendered":"

CJC 1295 ja Ipamorelin 10 mg - synergistinen GHRH- ja GHRP-sekoitus GH:n vapautumisen ja palautumisen tutkimukseen.<\/strong><\/p>\n

Koostumus: <\/strong>5 mg CJC 1295 (ei DAC) + 5 mg ipamoreliinia - Yhteens\u00e4: 10 mg lyofilisoitua peptidiseosta
Kategoria:<\/strong> Peptidiseos
Lomake:<\/strong> Injektiopullo, jossa on kylm\u00e4kuivattua jauhetta
Hallinto:<\/strong> Ihonalainen injektio sen j\u00e4lkeen, kun se on saatettu bakteriostaattiseen veteen<\/p>\n

Mik\u00e4 on CJC 1295 Ipamorelinin kanssa?<\/strong><\/p>\n

CJC 1295 with Ipamorelin on kaksitoiminen peptidiseos, jossa yhdistyv\u00e4t kaksi tutkittua kasvuhormonin stimulaattoria.
CJC 1295 on GHRH-analogi, joka edist\u00e4\u00e4 luonnollista GH:n vapautumista GHRH-reseptorien kautta.
Ipamoreliini on eritt\u00e4in selektiivinen GHRP-peptidi, joka laukaisee greliinireseptorit vahvistamaan GH-pulsseja vaikuttamatta kortisoliin tai prolaktiiniin tutkimusmalleissa.<\/p>\n

Osoitteessa 5 mg CJC 1295<\/strong> ja 5 mg ipamoreliinia<\/strong> injektiopulloa kohti, t\u00e4m\u00e4 sekoitus tarjoaa tasapainoisen ja synergistisen vaikutuksen tutkimuksiin, joissa tutkitaan GH:n erityst\u00e4, palautumisreittej\u00e4 ja metabolista suorituskyky\u00e4.<\/p>\n

Ihanteellinen regeneratiivisen biologian, suorituskyvyn palautumisen ja hormonaalisen signaloinnin tutkimukseen.<\/p>\n

T\u00e4rkeimm\u00e4t tutkimustulokset<\/strong><\/p>\n

Kahden mekanismin GH-vapautus: Ipamoreliini aktivoi greliinireseptoreita.<\/p>\n

Tasapainoinen synergia: 5 mg CJC ja 5 mg ipamoreliinia tukevat vakaita GH-pulsseja ja ennustettavaa farmakodynamiikkaa.<\/p>\n

Elvytys ja korjaus: Tutkimuksissa on osoitettu, ett\u00e4 se parantaa kudosten uudistumista ja proteiinisynteesi\u00e4.<\/p>\n

Laihan massan tuki: Tutkittu sen roolista v\u00e4h\u00e4rasvaisen kudoksen yll\u00e4pit\u00e4misess\u00e4 ja aineenvaihdunnan tehostamisessa.<\/p>\n

Eritt\u00e4in valikoiva profiili: Ipamoreliini tarjoaa kohdennettua GH:n vapautumista minimaalisilla kohteen ulkopuolisilla hormonaalisilla vaikutuksilla.<\/p>\n

Annostus ja k\u00e4ytt\u00f6<\/strong><\/p>\n

Rekonstruoidaan bakteriostaattisella vedell\u00e4 ennen k\u00e4ytt\u00f6\u00e4.<\/p>\n

Tyypillinen tutkimusv\u00e4li: 200-500 mcg yhdistetty\u00e4 sekoitusta sovellusta kohti.
Ihonalaisesti
1 - 3 kertaa p\u00e4iv\u00e4ss\u00e4 tutkimusprotokollan mukaan<\/p>\n

S\u00e4ilyt\u00e4 palautettu liuos j\u00e4\u00e4hdytettyn\u00e4 ja k\u00e4yt\u00e4 30 p\u00e4iv\u00e4n kuluessa.<\/p>\n

S\u00e4ilytysohjeet<\/strong><\/p>\n

S\u00e4ilytet\u00e4\u00e4n 2-8 C:ssa
Suojaa valolta ja kosteudelta
Ei saa j\u00e4\u00e4dytt\u00e4\u00e4
V\u00e4lt\u00e4 l\u00e4mp\u00f6tilan vaihteluita<\/p>\n

Miksi valita CJC 1295 Ipamorelinin kanssa?<\/strong><\/p>\n

T\u00e4m\u00e4n sekoituksen 5 mg plus 5 mg -suhde tarjoaa tarkan ja tehokkaan yhdistelm\u00e4n GHRH- ja GHRP-aktiivisuutta.
Sen koordinoitu kaksoismekanismi, vahva tutkimustaustausta ja luotettava GH-pulssiprofiili tekev\u00e4t siit\u00e4 yhden yleisimmin k\u00e4ytetyist\u00e4 sekoituksista palautumis-, aineenvaihdunta- ja regeneratiivisissa tutkimuksissa.<\/p>\n

Tutkitaan mahdollisuuksia CJC 1295, jossa on ipamoreliinia 10 mg<\/strong> kehittyneeseen GH- ja kudoskorjaustutkimukseen.<\/p>","protected":false},"excerpt":{"rendered":"

CJC 1295 with Ipamorelin 10 mg – Synergistic GHRH and GHRP Blend for GH Release and Recovery Research Composition: 5 mg CJC 1295 (no DAC) + 5 mg Ipamorelin – Total: 10 mg lyophilized peptide blendCategory: Peptide blendForm: Vial with freeze dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is CJC 1295 with Ipamorelin? CJC 1295 with Ipamorelin is a dual action peptide blend combining two research backed growth hormone stimulators.CJC 1295 is a GHRH analog that promotes natural GH release via GHRH receptors.Ipamorelin is a highly selective GHRP peptide that triggers ghrelin receptors to amplify GH pulses without affecting cortisol or prolactin in research models. With 5 mg CJC 1295 and 5 mg Ipamorelin per vial, this blend delivers a balanced and synergistic effect for studies exploring GH secretion, recovery pathways and metabolic performance. Ideal for research in regenerative biology, performance recovery and endocrine signaling. Key Research Findings Dual Mechanism GH Release: CJC activates GHRH pathways, Ipamorelin activates ghrelin receptors. Balanced Synergy: 5 mg CJC and 5 mg Ipamorelin support stable GH pulses and predictable pharmacodynamics. Recovery and Repair: Shown in research to enhance tissue regeneration and protein synthesis. Lean Mass Support: Investigated for its role in maintaining lean tissue and improving metabolic output. Highly Selective Profile: Ipamorelin offers targeted GH release with minimal off target hormonal effects. Dosage and Application Reconstitute with bacteriostatic water before use. Typical research range: 200 to 500 mcg of the combined blend per applicationSubcutaneously1 to 3 times daily depending on study protocol Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2 to 8 CProtect from light and moistureDo not freezeAvoid temperature fluctuations Why Choose CJC 1295 with Ipamorelin? The 5 mg plus 5 mg ratio of this blend provides a precise and effective combination of GHRH and GHRP activity.Its coordinated dual mechanism, strong research background and reliable GH pulse profile make it one of the most commonly used blends in recovery, metabolic and regenerative studies. Explore the potential of CJC 1295 with Ipamorelin 10 mg for advanced GH and tissue repair research.<\/p>","protected":false},"featured_media":21990,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,27,28],"product_tag":[],"class_list":["post-21981","product","type-product","status-publish","has-post-thumbnail","product_cat-all-products","product_cat-peptidesandresearchdrugs","product_cat-regenerationandtissuehealing","entry","has-media","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/21981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/comments?post=21981"}],"version-history":[{"count":3,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/21981\/revisions"}],"predecessor-version":[{"id":39736,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/21981\/revisions\/39736"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/media\/21990"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/media?parent=21981"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_brand?post=21981"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_cat?post=21981"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_tag?post=21981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}